发布求助
文献互助 智能选刊 最新文献

Medische Oncologie最新文献

筛选
英文 中文
Overzicht van klinisch noodzakelijke targets en moleculaire diagnostiek per tumortype 按肿瘤类型划分的临床必需靶点和分子诊断概述
Medische Oncologie Pub Date : 2024-02-01 DOI: 10.24078/onco.1970.1.27464
Nina Wubben
{"title":"Overzicht van klinisch noodzakelijke targets en moleculaire diagnostiek per tumortype","authors":"Nina Wubben","doi":"10.24078/onco.1970.1.27464","DOIUrl":"https://doi.org/10.24078/onco.1970.1.27464","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"71 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140467881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gemcitabine als onderhoudsbehandeling na eerstelijnsbehandeling voor het irresectabel maligne mesothelioom 吉西他滨作为不可切除恶性间皮瘤一线治疗后的维持治疗药物
Medische Oncologie Pub Date : 2024-02-01 DOI: 10.24078/onco.1970.1.27474
NVMO-commissie BOM
{"title":"Gemcitabine als onderhoudsbehandeling na eerstelijnsbehandeling voor het irresectabel maligne mesothelioom","authors":"NVMO-commissie BOM","doi":"10.24078/onco.1970.1.27474","DOIUrl":"https://doi.org/10.24078/onco.1970.1.27474","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"46 25","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140464396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant nivolumab bij stadium IIIb, IIIc of IV melanoom na volledige chirurgische resectie IIIb、IIIc 或 IV 期黑色素瘤完全手术切除后的 nivolumab 辅助治疗
Medische Oncologie Pub Date : 2023-12-01 DOI: 10.24078/onco.1970.1.24174
Redactie
{"title":"Adjuvant nivolumab bij stadium IIIb, IIIc of IV melanoom na volledige chirurgische resectie","authors":"Redactie","doi":"10.24078/onco.1970.1.24174","DOIUrl":"https://doi.org/10.24078/onco.1970.1.24174","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"160 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139013590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
NRS: Tepotinib voor het gemetastaseerd niet-kleincellig longcarcinoom met een MET exon 14 skipping-mutatie NRS：特泊替尼治疗具有MET 14外显子跳越突变的转移性非小细胞肺癌
Medische Oncologie Pub Date : 2023-12-01 DOI: 10.24078/onco.1970.1.24173
Redactie
{"title":"NRS: Tepotinib voor het gemetastaseerd niet-kleincellig longcarcinoom met een MET exon 14 skipping-mutatie","authors":"Redactie","doi":"10.24078/onco.1970.1.24173","DOIUrl":"https://doi.org/10.24078/onco.1970.1.24173","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"1141 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139014120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Later pijn en behoud van kwaliteit van leven na behandeling met 177 Lu-PSMA-617 使用 177 Lu-PSMA-617 治疗后的后期疼痛和生活质量维持情况
Medische Oncologie Pub Date : 2023-12-01 DOI: 10.24078/onco.2023.12.24160
Nina Wubben
{"title":"Later pijn en behoud van kwaliteit van leven na behandeling met 177 Lu-PSMA-617","authors":"Nina Wubben","doi":"10.24078/onco.2023.12.24160","DOIUrl":"https://doi.org/10.24078/onco.2023.12.24160","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"201 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139016361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant dabrafenib in combinatie met trametinib bij stadium III melanoom 达拉非尼联合曲美替尼辅助治疗 III 期黑色素瘤
Medische Oncologie Pub Date : 2023-12-01 DOI: 10.24078/onco.1970.1.24175
Redactie
{"title":"Adjuvant dabrafenib in combinatie met trametinib bij stadium III melanoom","authors":"Redactie","doi":"10.24078/onco.1970.1.24175","DOIUrl":"https://doi.org/10.24078/onco.1970.1.24175","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"315 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139018378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
NRS: Capmatinib voor het gemetastaseerd niet-kleincellig longcarcinoom met een MET exon 14 skipping-mutatie NRS：卡帕替尼治疗MET第14外显子跳越突变的转移性非小细胞肺癌
Medische Oncologie Pub Date : 2023-12-01 DOI: 10.24078/onco.1970.1.24172
Redactie
{"title":"NRS: Capmatinib voor het gemetastaseerd niet-kleincellig longcarcinoom met een MET exon 14 skipping-mutatie","authors":"Redactie","doi":"10.24078/onco.1970.1.24172","DOIUrl":"https://doi.org/10.24078/onco.1970.1.24172","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"1543 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139019202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant pembrolizumab bij stadium III melanoom 帕姆单抗辅助治疗 III 期黑色素瘤
Medische Oncologie Pub Date : 2023-12-01 DOI: 10.24078/onco.1970.1.24176
Redactie
{"title":"Adjuvant pembrolizumab bij stadium III melanoom","authors":"Redactie","doi":"10.24078/onco.1970.1.24176","DOIUrl":"https://doi.org/10.24078/onco.1970.1.24176","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"156 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139024180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ivosidenib als tweede- of derdelijnsbehandeling bij het gevorderd IDH1-gemuteerd cholangiocarcinoom 伊沃西地尼作为二线或三线治疗晚期IDH1突变胆管癌的药物
Medische Oncologie Pub Date : 2023-11-01 DOI: 10.24078/onco.1970.1.23981
NVMO-commissie BOM
{"title":"Ivosidenib als tweede- of derdelijnsbehandeling bij het gevorderd IDH1-gemuteerd cholangiocarcinoom","authors":"NVMO-commissie BOM","doi":"10.24078/onco.1970.1.23981","DOIUrl":"https://doi.org/10.24078/onco.1970.1.23981","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"84 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139294708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orale SERD amcenestrant niet beter dan fulvestrant bij vergevorderde borstkanker 口服 SERD 安非他酮治疗晚期乳腺癌的效果不优于氟维司群
Medische Oncologie Pub Date : 2023-11-01 DOI: 10.24078/onco.1970.1.23968
Nina Wubben
{"title":"Orale SERD amcenestrant niet beter dan fulvestrant bij vergevorderde borstkanker","authors":"Nina Wubben","doi":"10.24078/onco.1970.1.23968","DOIUrl":"https://doi.org/10.24078/onco.1970.1.23968","url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139300073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信